Correlation Between Iteos Therapeutics and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Sana Biotechnology, you can compare the effects of market volatilities on Iteos Therapeutics and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Sana Biotechnology.
Diversification Opportunities for Iteos Therapeutics and Sana Biotechnology
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Iteos and Sana is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and Sana Biotechnology
Given the investment horizon of 90 days Iteos Therapeutics is expected to generate 0.5 times more return on investment than Sana Biotechnology. However, Iteos Therapeutics is 1.98 times less risky than Sana Biotechnology. It trades about -0.14 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.39 per unit of risk. If you would invest 893.00 in Iteos Therapeutics on August 28, 2024 and sell it today you would lose (74.00) from holding Iteos Therapeutics or give up 8.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iteos Therapeutics vs. Sana Biotechnology
Performance |
| Timeline |
| Iteos Therapeutics |
| Sana Biotechnology |
Iteos Therapeutics and Sana Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iteos Therapeutics and Sana Biotechnology
The main advantage of trading using opposite Iteos Therapeutics and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
| Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |